Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta-analysis of cardiovascular outcome trials of novel glucose-lowering agents.
Setor Kwadzo KunutsorFrancesco ZaccardiVictoria G BalasubramanianClare L GilliesVanita R ArodaSamuel SeiduMelanie Jane DaviesKamlesh Khunti F MedSciPublished in: Diabetes, obesity & metabolism (2024)
SGLT-2is and GLP-1RAs showed consistent risk reductions in macrovascular and microvascular outcomes. The vascular benefits of SGLT-2is and GLP-1RAs in patients with T2D extend beyond mere glycaemic control.